U.S. Physical Therapy, Inc. (NYSE:USPH) Receives Consensus Rating of “Buy” from Brokerages

U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus recommendation of “Buy” from the five ratings firms that are covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $114.00.

USPH has been the topic of a number of analyst reports. Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the sale, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Nancy Ham sold 1,172 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the transaction, the director now directly owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,412 shares of company stock worth $706,605. 1.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Large investors have recently modified their holdings of the stock. State Street Corp raised its stake in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after acquiring an additional 61,474 shares in the last quarter. Southernsun Asset Management LLC raised its position in shares of U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after acquiring an additional 52,062 shares in the last quarter. Penn Davis Mcfarland Inc. acquired a new position in U.S. Physical Therapy in the third quarter worth $2,552,000. Finally, Rockefeller Capital Management L.P. boosted its holdings in U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after purchasing an additional 25,393 shares during the period.

U.S. Physical Therapy Price Performance

NYSE:USPH opened at $86.99 on Friday. U.S. Physical Therapy has a 12-month low of $76.18 and a 12-month high of $113.63. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 92.54, a price-to-earnings-growth ratio of 4.23 and a beta of 1.48. The company’s 50-day moving average is $92.83 and its two-hundred day moving average is $89.05. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were paid a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 2.02%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is currently 187.23%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.